Literature DB >> 29439909

Prediction of outcome in asphyxiated newborns treated with hypothermia: Is a MRI scoring system described before the cooling era still useful?

Fatema Al Amrani1, Jaclyn Marcovitz2, Priscille-Nice Sanon2, May Khairy3, Christine Saint-Martin4, Michael Shevell1, Pia Wintermark5.   

Abstract

AIM: To determine whether an MRI scoring system, which was validated in the pre-cooling era, can still predict the neurodevelopmental outcome of asphyxiated newborns treated with hypothermia at 2 years of age. PATIENTS AND
METHOD: We conducted a retrospective cohort study of asphyxiated newborns treated with hypothermia. An MRI scoring system, which was validated in the pre-cooling era, was used to grade the severity of brain injury on the neonatal brain MRI. Their neurodevelopment was assessed around 2 years of age; adverse outcome included cerebral palsy, global developmental delay, and/or epilepsy.
RESULTS: One hundred and sixty-nine newborns were included. Among the 131 newborns who survived and had a brain MRI during the neonatal period, 92% were evaluated around 2 years of age or later. Of these newborns, 37% displayed brain injury, and 23% developed an adverse outcome. Asphyxiated newborns treated with hypothermia who had an adverse outcome had a significantly higher MRI score (p <0.001) compared to those without an adverse outcome.
CONCLUSION: An MRI scoring system that was validated before the cooling era is still able to reliably differentiate which of the asphyxiated newborns treated with hypothermia were more prone to develop an adverse outcome around 2 years of age.
Copyright © 2018 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Birth asphyxia; Brain; Cerebral palsy; Epilepsy; Global developmental delay; Hypothermia; Magnetic resonance imaging; Neonatal encephalopathy; Neurodevelopment; Newborn

Mesh:

Year:  2018        PMID: 29439909     DOI: 10.1016/j.ejpn.2018.01.017

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  6 in total

Review 1.  Neuroimaging in the term newborn with neonatal encephalopathy.

Authors:  Jessica L Wisnowski; Pia Wintermark; Sonia L Bonifacio; Christopher D Smyser; A James Barkovich; A David Edwards; Linda S de Vries; Terrie E Inder; Vann Chau
Journal:  Semin Fetal Neonatal Med       Date:  2021-10-29       Impact factor: 3.726

2.  Apgar Scores at 10 Minutes and Outcomes in Term and Late Preterm Neonates with Hypoxic-Ischemic Encephalopathy in the Cooling Era.

Authors:  Marina Ayrapetyan; Kiran Talekar; Kathleen Schwabenbauer; David Carola; Kolawole Solarin; Dorothy McElwee; Susan Adeniyi-Jones; Jay Greenspan; Zubair H Aghai
Journal:  Am J Perinatol       Date:  2018-09-12       Impact factor: 1.862

3.  Association of Routinely Measured Proinflammatory Biomarkers With Abnormal MRI Findings in Asphyxiated Neonates Undergoing Therapeutic Hypothermia.

Authors:  Maria Ruhfus; Stamatios Giannakis; Mona Markus; Anja Stein; Thomas Hoehn; Ursula Felderhoff-Mueser; Hemmen Sabir
Journal:  Front Pediatr       Date:  2021-03-29       Impact factor: 3.418

4.  Discussing brain magnetic resonance imaging results for neonates with hypoxic-ischemic encephalopathy treated with hypothermia: A challenge for clinicians and parents.

Authors:  Ariel Cascio; Amaryllis Ferrand; Eric Racine; Marie St-Hilaire; Priscille-Nice Sanon; Andreea Gorgos; Pia Wintermark
Journal:  eNeurologicalSci       Date:  2022-09-11

5.  Mechanical Ventilation, Partial Pressure of Carbon Dioxide, Increased Fraction of Inspired Oxygen and the Increased Risk for Adverse Short-Term Outcomes in Cooled Asphyxiated Newborns.

Authors:  Stamatios Giannakis; Maria Ruhfus; Mona Markus; Anja Stein; Thomas Hoehn; Ursula Felderhoff-Mueser; Hemmen Sabir
Journal:  Children (Basel)       Date:  2021-05-21

6.  MRI combined with early clinical variables are excellent outcome predictors for newborn infants undergoing therapeutic hypothermia after perinatal asphyxia.

Authors:  Marianne Thoresen; Sally Jary; Lars Walløe; Mathias Karlsson; Miriam Martinez-Biarge; Ela Chakkarapani; Frances M Cowan
Journal:  EClinicalMedicine       Date:  2021-05-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.